Trials / Withdrawn
WithdrawnNCT02405793
Meloxicam SoluMatrix® Capsules vs Meloxicam Tablets to Treat Osteoarthritis Pain
A Phase 2b, Multicenter, Randomized, Single Blind, Fixed Dose, Parallel Group Study to Evaluate the Efficacy and Safety of Meloxicam SoluMatrix® [Test] Capsules and Meloxicam Tablets in Patients With Pain Due to Osteoarthritis of the Knee or Hip
- Status
- Withdrawn
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Iroko Pharmaceuticals, LLC · Industry
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the safety and efficacy of a low dose and a high dose of Meloxicam SoluMatrix® Capsules versus Meloxicam Tablets for the treatment of pain due to osteoarthritis of the knee or hip.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Meloxicam Test Capsules | |
| DRUG | Meloxicam Test Capsules | |
| DRUG | Meloxicam Tablets |
Timeline
- Start date
- 2015-05-01
- Primary completion
- 2015-07-01
- Completion
- 2015-07-01
- First posted
- 2015-04-01
- Last updated
- 2015-07-10
Source: ClinicalTrials.gov record NCT02405793. Inclusion in this directory is not an endorsement.